ERCC1 and lung carcinoma: For the ERCC1 gene, the defective ERCC1 gene could increase the incidence of vascular diseases [35], and genetic polymorphisms of ERCC1 could affect the efficiency of chemotherapy, as well as the susceptibility of a variety of diseases, including lung cancer and several cardiovascular diseases [36,37,38].